CRUSH RESISTANT DELAYED-RELEASE DOSAGE FORMS

The invention relates to a dosage form comprising a physiologically effective amount of a physiologically active substance (A), a synthetic, semi-synthetic or natural polymer (C), optionally one or more physiologically acceptable auxiliary, substances (B) and optionally a synthetic, semi-synthetic o...

Full description

Saved in:
Bibliographic Details
Main Authors KUGELMANN, Heinrich, BARTHOLOMÄUS, Johannes, ASHWORTH, Judy, ARKENAU-MARIC, Elisabeth
Format Patent
LanguageEnglish
Published 27.12.2018
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The invention relates to a dosage form comprising a physiologically effective amount of a physiologically active substance (A), a synthetic, semi-synthetic or natural polymer (C), optionally one or more physiologically acceptable auxiliary, substances (B) and optionally a synthetic, semi-synthetic or natural wax (D), wherein the dosage form exhibits a resistance to crushing of at least 400 N and wherein under physiological conditions the release of the physiologically active substance (A) from the dosage form is at least partially delayed.
Bibliography:Application Number: US201816016924